The global landscape of lean metabolic dysfunction-associated steatotic liver disease: insight from Asia and the West
{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a leading global cause of chronic liver disease, affecting 25-30% of the population. While MASLD is traditionally associated with obesity, lean MASLD-a subset characterized by hepa... ...
